# FDA 483 - Alan G. Garscadden, M.D. - July 21, 2023

Source: https://www.globalkeysolutions.net/records/483/alan-g-garscadden-md/41c9ec82-4e4f-4ce7-ab30-b325a707f3a2

> FDA 483 for Alan G. Garscadden, M.D. on July 21, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Alan G. Garscadden, M.D.
- Inspection Date: 2023-07-21
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Alan G. Garscadden, M.D. in Colorado Springs, CO, revealed a significant issue regarding the conduct of an investigation. The principal investigator failed to report all adverse events and medical history according to the study protocol. This indicates a lack of adherence to the investigational plan and signed statement of investigator.

## Related Documents

- [483 - 2021-10-22](https://www.globalkeysolutions.net/records/483/alan-g-garscadden-md/e1c1acae-c9b7-4b1e-938c-d0c6070dd2ab)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/courtney-r-bratina/3ad4bfd5-d0da-4801-8e90-a5a3ba9291c3)

Company: https://www.globalkeysolutions.net/companies/alan-g-garscadden-md/762ab785-c09a-4801-951d-aa7a35169abc

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face